Physician profile
Melike Arslan
NPI 1043337439
$1,145.25
in general payments reported to CMS, 2019-2025
19 companies · $198 in 2025
The $198 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.44 · 2020: $86.79 · 2022: $337 · 2023: $167 · 2024: $268 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $632.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $632.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $151.24 | 2019-2025 | Lifevest |
| Abiomed | $144.77 | 2022 | |
| Inari Medical, INC. | $109.66 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Penumbra, INC. | $102.51 | 2023-2025 | Penumbra System, Indigo System |
| Angiodynamics, INC. | $81.21 | 2019-2020 | |
| Eli Lilly and Company | $80.93 | 2022 | |
| Abbott Laboratories | $74.38 | 2024-2025 | Coroflow, Nc Trek Neo, Eterna |
| Medtronic Vascular, INC. | $55.16 | 2019-2020 | |
| Edwards Lifesciences Corporation | $50.50 | 2024-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Boston Scientific Corporation | $44.99 | 2022-2024 | Ekosonic |
| Shockwave Medical, INC | $37.28 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Heartflow, INC. | $36.49 | 2023 | Ffrct |
| Medtronic, INC. | $34.82 | 2022 | |
| Teleflex LLC | $32.46 | 2025 | Supercross |
| Cardiovascular Systems INC. | $28.90 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $26.55 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Cook Medical LLC | $23.72 | 2019 | |
| Merck Sharp & Dohme LLC | $16.16 | 2022 | |
| Scpharmaceuticals INC. | $13.52 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melike Arslan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.